ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$4.46
Tradestie Score
46
Market Cap
$35.25M
Analyst Upside
+101.8%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.42
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.34
|
$202.58M | - | 34 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.76
|
$199.71M | - | 41 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.00
|
$154.27M | - | 48 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.88
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.15
|
$110.20M | - | 41 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$0.23
|
$106.00M | - | 50 | Compare |
More ANTX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry